In a small sub-population of MCC cells, induction of MICA/B surface expression by treatment with HDAC inhibitors in combination with mithramycin A was not as pronounced as in the main population (Fig. 4c and Supplementary Fig. 8a). The gene discussed is HDAC9; the disease is Merkel cell skin cancer.